Dose Level -1
Dose Level -1 is a biological therapy with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Clinical Trials (9)
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
All 9 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 9